Array Biopharma to Report Financial Results for the Third Quarter of Fiscal 2006 on May 1, 2006

Apr 25, 2006, 01:00 ET from Array Biopharma

    BOULDER, Colo., April 25 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
 (Nasdaq:   ARRY) will report financial results for the third quarter of
 fiscal 2006 on Monday, May 1, 2006, at 4:30 p.m. Eastern time and hold a
 conference call on Tuesday, May 2, 2006, at 9:00 a.m. Eastern time. Robert
 E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial
 Officer, will lead the call.
     Conference Call Information
     Date:       Tuesday, May 2, 2006
     Time:       9:00 a.m. eastern time
     Toll-Free:  (800) 967-7135
     Toll:       (719) 457-2626
     Pass Code:  4239427
     Web Cast:
     There will be a replay of the conference call for one week, which can
 be accessed in the United States by dialing toll-free (888) 203-1112, and
 outside the United States (719) 457-0820. The access code is 4239427.
 Replay of the call will also be available as a web cast on Array's web site
     Array BioPharma Inc. is a biopharmaceutical company focused on the
 discovery, development and commercialization of targeted small molecule
 drugs to treat life threatening and debilitating diseases. Our proprietary
 drug development pipeline is focused on the treatment of cancer and
 inflammatory disease and includes clinical candidates that are designed to
 regulate therapeutically important targets. In addition, leading
 pharmaceutical and biotechnology companies access Array's drug discovery
 technologies and expertise through collaborations to design, create,
 optimize and evaluate drug candidates across a broad range of therapeutic
 areas. For more information on Array, please go to

SOURCE Array Biopharma